Biosimilars & Biobetters, Interview Series for 2017 -- An Interview with Glenn Kazo, President from Prolong Pharmaceuticals.

An Interview with Glenn Kazo, President from Prolong Pharmaceuticals. With over 25 years of experience, Glenn Kazo is the President and Chief Operating Officer of Prolong Pharmaceuticals LLC, a privately held company with portfolio of hematology and oncology products in clinical development. Over the last decade Kazo has been very active in the advancement of Biosimilars and BioBetters, both as an industry speaker and in leading several drug development programs...